SAN

74.05

-1.45%↓

ARGX

714.6

-0.06%↓

SHL.DE

34.23

-1.81%↓

PHIA

22.37

-2.4%↓

FRE

35.54

-2.71%↓

SAN

74.05

-1.45%↓

ARGX

714.6

-0.06%↓

SHL.DE

34.23

-1.81%↓

PHIA

22.37

-2.4%↓

FRE

35.54

-2.71%↓

SAN

74.05

-1.45%↓

ARGX

714.6

-0.06%↓

SHL.DE

34.23

-1.81%↓

PHIA

22.37

-2.4%↓

FRE

35.54

-2.71%↓

SAN

74.05

-1.45%↓

ARGX

714.6

-0.06%↓

SHL.DE

34.23

-1.81%↓

PHIA

22.37

-2.4%↓

FRE

35.54

-2.71%↓

SAN

74.05

-1.45%↓

ARGX

714.6

-0.06%↓

SHL.DE

34.23

-1.81%↓

PHIA

22.37

-2.4%↓

FRE

35.54

-2.71%↓

Inicio・Lista de Acciones・Nanobiotix

N
Nanobiotix

Cerrado

32.62 -3.78

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

32.36

Máximo

33.92

Métricas clave
By Trading Economics
Ingresos	-13M -19M
Ventas	-24M 3M
Margen de beneficios	-618.236
Empleados	100
EBITDA	-14M -13M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+61.57% upside

Dividendos
By Dow Jones
Próximas Ganancias	3 jun 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	424M 1.8B
Apertura anterior	36.4
Cierre anterior	32.62

Nanobiotix Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 may 2026, 23:44 UTC

Charlas de Mercado

Nikkei May Remain Rangebound Amid Middle East Uncertainty -- Market Talk

31 may 2026, 23:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

31 may 2026, 23:36 UTC

Charlas de Mercado

Oil Rises Amid Few Signs of Strait of Hormuz's Reopening -- Market Talk

31 may 2026, 23:36 UTC

Charlas de Mercado

Watch for Data-Center Investment in Australia's 1Q GDP Print -- Market Talk

31 may 2026, 22:54 UTC

Adquisiciones, fusiones, absorciones

Berkshire Hathaway to Buy Homebuilder Taylor Morrison for $6.8 Billion -- WSJ

29 may 2026, 23:08 UTC

Adquisiciones, fusiones, absorciones

Family Offices Bypass Private Equity and Go Direct -- Barrons.com

29 may 2026, 23:06 UTC

Adquisiciones, fusiones, absorciones

After a Series of Sales, Hims Director Buys Company Shares -- Barrons.com

29 may 2026, 20:53 UTC

Ganancias

Oil Declines Lift Stocks to Fresh Records -- WSJ

29 may 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

29 may 2026, 20:33 UTC

Charlas de Mercado

Canada Meets Only One of Three Criteria To Declare Recession -- Market Talk

29 may 2026, 20:11 UTC

Ganancias

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29 may 2026, 19:47 UTC

Ganancias

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

29 may 2026, 19:36 UTC

Charlas de Mercado

U.S. Natural Gas Futures End Month With Gains -- Market Talk

29 may 2026, 19:34 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

29 may 2026, 19:34 UTC

Charlas de Mercado

Over Half of Canadian Industries Growing, Undermining Recession Talk -- Market Talk

29 may 2026, 19:22 UTC

Charlas de Mercado

Oil Falls as U.S., Iran Expected to Reach Agreement -- Market Talk

29 may 2026, 19:05 UTC

Adquisiciones, fusiones, absorciones

Universal Music Group Rejects $65 Billion Takeover Bid From Bill Ackman's Pershing Square -- Barrons.com

29 may 2026, 18:19 UTC

Charlas de Mercado

Canada Technical Recession Chatter Rife But Per-Capita GDP Was Up -- Market Talk

29 may 2026, 18:12 UTC

Adquisiciones, fusiones, absorciones

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman -- WSJ

29 may 2026, 18:11 UTC

Charlas de Mercado

Canada Households Reaching Limit at Keeping Spending in Positive Territory -- Market Talk

29 may 2026, 18:10 UTC

Charlas de Mercado

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29 may 2026, 17:55 UTC

Ganancias

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29 may 2026, 17:55 UTC

Charlas de Mercado

NEAR Protocol Nearly Doubles in May -- Market Talk

29 may 2026, 17:38 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises for Fifth Straight Week -- Market Talk

29 may 2026, 17:00 UTC

Ganancias

Okta Stock Soars After Earnings. Results Aren't the Real Catalyst. -- Barrons.com

29 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

29 may 2026, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

29 may 2026, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

29 may 2026, 16:02 UTC

Charlas de Mercado

Gold Extend Gains as Investors Await U.S.-Iran Deal News -- Market Talk

29 may 2026, 15:55 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Nanobiotix previsión

Precio Objetivo

By TipRanks

61.57% repunte

Estimación a 12 Meses

Media 55 EUR 61.57%

Máximo 60 EUR

Mínimo 45 EUR

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Nanobiotix Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Nanobiotix Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.